RAYMOND JAMES FINANCIAL INC

Raymond James keeps its Q2 2026 portfolio balanced, boosting positions in Ginkgo Bioworks, Upwork, and Fidelity’s consumer‑discretionary ETF for steady, diversified growth.

Raymond James backs growth‑led stocks: strong‑buy on Alphabet for AI & cloud, U.S. Bancorp’s earnings boost, and Prologis’ logistics boom. Discover the brokerage’s insights on high‑potential sectors.

Raymond James expands coverage of Red River Bancshares & First Bancorp, noting earnings beats, ROE strengths, revenue gaps and valuation cautions.

Raymond James lifts CCL Industries target price, but analysts should scrutinize earnings assumptions, conflict of interest, and the company’s real‑world impact on workers and suppliers.

Raymond James reports steady Q1 2026 asset growth driven by private‑client gains and rising fee‑based accounts, highlighting its resilient fee‑based model and strategic diversification.

Raymond James Financial’s May 2026 8‑K filings reveal a $0.54 dividend and rising assets, but lack key profitability, risk, and strategy details, raising transparency concerns.

Raymond James raises its quarterly dividend to $0.45, while its share price stays flat – learn how this steady payout fits into a broader income‑focused portfolio strategy.

Raymond James’ recent S‑8 filing, dividend pledge and 13F‑HR ETF moves reveal a strategy that balances low‑cost capital, shareholder returns and institutional influence, offering investors insight into its growth and risk profile.

Raymond James’ Q1 earnings beat expectations, driven by steady investment‑banking fees and robust trading income, while new real‑estate holdings signal growth opportunities amid evolving regulation.

Raymond James lifts target on key natural‑gas producer after earnings beat, cost discipline, and modest upside; analysts remain cautiously positive amid market volatility.